333 related articles for article (PubMed ID: 22056608)
1. Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats.
Dean RL; Eyerman D; Todtenkopf MS; Turncliff RZ; Bidlack JM; Deaver DR
Pharmacol Biochem Behav; 2012 Jan; 100(3):530-7. PubMed ID: 22056608
[TBL] [Abstract][Full Text] [Related]
2. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
4. The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats.
Uhari-Väänänen J; Eteläinen T; Bäckström P; Oinio V; Carroll FI; Raasmaja A; Kiianmaa K; Piepponen P
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1386-1396. PubMed ID: 31679889
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
7. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
[TBL] [Abstract][Full Text] [Related]
8. Delta receptor antagonism, ethanol taste reactivity, and ethanol consumption in outbred male rats.
Higley AE; Kiefer SW
Alcohol; 2006 Nov; 40(3):143-50. PubMed ID: 17418693
[TBL] [Abstract][Full Text] [Related]
9. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
Ciccocioppo R; Martin-Fardon R; Weiss F
Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
[TBL] [Abstract][Full Text] [Related]
10. Improved effect of the combination naltrexone/D-penicillamine in the prevention of alcohol relapse-like drinking in rats.
Orrico A; Martí-Prats L; Cano-Cebrián MJ; Granero L; Polache A; Zornoza T
J Psychopharmacol; 2014 Jan; 28(1):76-81. PubMed ID: 24306132
[TBL] [Abstract][Full Text] [Related]
11. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
Seely KA; Brents LK; Franks LN; Rajasekaran M; Zimmerman SM; Fantegrossi WE; Prather PL
Neuropharmacology; 2012 Oct; 63(5):905-15. PubMed ID: 22771770
[TBL] [Abstract][Full Text] [Related]
12. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
13. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption.
Kuzmin A; Stenback T; Liljequist S
Eur J Pharmacol; 2008 Apr; 584(2-3):352-6. PubMed ID: 18339371
[TBL] [Abstract][Full Text] [Related]
14. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
Kato H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
[TBL] [Abstract][Full Text] [Related]
16. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
Gallate JE; Mallet PE; McGregor IS
Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
[TBL] [Abstract][Full Text] [Related]
17. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
18. The effect of baclofen alone and in combination with naltrexone on ethanol consumption in the rat.
Stromberg MF
Pharmacol Biochem Behav; 2004 Aug; 78(4):743-50. PubMed ID: 15301930
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
Campbell VC; Taylor RE; Tizabi Y
Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
[TBL] [Abstract][Full Text] [Related]
20. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference.
Nestby P; Schoffelmeer AN; Homberg JR; Wardeh G; De Vries TJ; Mulder AH; Vanderschuren LJ
Psychopharmacology (Berl); 1999 Mar; 142(3):309-17. PubMed ID: 10208324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
